Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
The telehealth provider said it would no longer offer access to a compounded version of Wegovy after Novo Nordisk had threatened legal action. on.wsj.com/3O5r9Dp
https://on.wsj.com/3O5r9Dp
2026-02-09T09:42:56.652Z